Schisandra Sphenanthera

17 interactions 3 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Entrectinib Cyclosporine Injection Cyclosporine Ophthalmic Doxorubicin Encorafenib Lefamulin
17 Major
All (17) Major (17)

Major

Schisandra Sphenanthera Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Schisandra Sphenanthera Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Schisandra Sphenanthera Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Schisandra Sphenanthera Avapritinib Ayvakit Increased avapritinib exposure and an increased risk of the incidence and severity of adverse reactions Details Schisandra Sphenanthera Bedaquiline Sirturo Increased bedaquiline exposure Details Schisandra Sphenanthera Bosutinib Bosulif Increased bosutinib exposure Details Schisandra Sphenanthera Budesonide Entocort Increased budesonide exposure Details Schisandra Sphenanthera Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Schisandra Sphenanthera Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Schisandra Sphenanthera Cyclosporine Injection Atopica Increased cycloSPORINE exposure Details Schisandra Sphenanthera Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure Details Schisandra Sphenanthera Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Schisandra Sphenanthera Encorafenib Braftovi Increased encorafenib exposure and an increased risk of encorafenib-related adverse events Details Schisandra Sphenanthera Entrectinib Rozlytrek Increased entrectinib exposure and an increased frequency or severity of adverse reactions Details Schisandra Sphenanthera Fentanyl Transdermal Patch Duragesic® Increased fentaNYL exposure and an increased risk of prolonged opioid effects Details Schisandra Sphenanthera Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Schisandra Sphenanthera Lurbinectedin Injection Zepzelca Increased lurbinectedin exposure and an increased risk of lurbinectedin-related adverse reactions Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.